PDE 4 inhibitors (CJ)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePDE 4 inhibitors (CJ)

Drug Alias NamePDE 4 inhibitors (Cheil Je Dang)5CC

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodieterase 4 inhibitors

TargetsPhosphodieterase 4

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCj Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCj Corp

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A